Causes of and Prevention Strategies for Hepatocellular Carcinoma

被引：47

作者：

Cabibbo, Giuseppe

Maida, Marcello

Genco, Chiara

Antonucci, Michela ^{[2
]}

Comma, Calogero ^{[1
]}

机构：

[1] Univ Palermo, Sez Gastroenterol, Dipartimento Biomed Med Interna & Specialist, DIBIMIS, I-90127 Palermo, Italy

[2] Univ Palermo, Dipartimento Oncol, Div Chirurg Gen & Oncol, I-90127 Palermo, Italy

来源：

SEMINARS IN ONCOLOGY | 2012年 / 39卷 / 04期

关键词：

CHRONIC HEPATITIS-B; NONALCOHOLIC FATTY LIVER; TERM-FOLLOW-UP; VIRUS-RELATED CIRRHOSIS; PLACEBO-CONTROLLED TRIAL; BODY-MASS INDEX; INTERFERON THERAPY; UNITED-STATES; RISK-FACTORS; CANCER-RISK;

D O I：

10.1053/j.seminoncol.2012.05.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：374 / 383

页数：10

共 127 条

[1]

Adami HO, 2001, EUR J CANCER, V37, pS118

[2]

Colchicine versus PEG-interferon alfa 2b long term therapy: Results of the 4 year copilot trial [J].

Afdhal, N. H. ;

Levine, R. ;

Brown, R., Jr. ;

Freilich, B. ;

O'Brien, M. ;

Brass, C. .

JOURNAL OF HEPATOLOGY, 2008, 48 :S4-S4

[3]

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [J].

Aithal, Guruprasad P. ;

Thomas, James A. ;

Kaye, Philip V. ;

Lawson, Adam ;

Ryder, Stephen D. ;

Spendlove, Ian ;

Austin, Andrew S. ;

Freeman, Jan G. ;

Morgan, Linda ;

Weeber, Jonathan .

GASTROENTEROLOGY, 2008, 135 (04) :1176-1184

[4]

Almasio P, 1999, EVIDENCE BASED GASTR, P305

[5]

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].

Altekruse, Sean F. ;

McGlynn, Katherine A. ;

Reichman, Marsha E. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491

[6]

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway [J].

Awazawa, Motoharu ;

Ueki, Kohjiro ;

Inabe, Kazunori ;

Yamauchi, Toshimasa ;

Kaneko, Kazuma ;

Okazaki, Yukiko ;

Bardeesy, Nabeel ;

Ohnishi, Shin ;

Nagai, Ryozo ;

Kadowaki, Takashi .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 382 (01) :51-56

[7]

Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].

Bedogni, G ;

Miglioli, L ;

Masutti, F ;

Tiribelli, C ;

Marchesini, G ;

Bellentani, S .

HEPATOLOGY, 2005, 42 (01) :44-52

[8]

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].

Belfort, Renata ;

Harrison, Stephen A. ;

Brown, Kenneth ;

Darland, Celia ;

Finch, Joan ;

Hardies, Jean ;

Balas, Bogdan ;

Gastaldelli, Amalia ;

Tio, Fermin ;

Pulcini, Joseph ;

Berria, Rachele ;

Ma, Jennie Z. ;

Dwivedi, Sunil ;

Havranek, Russell ;

Fincke, Chris ;

DeFronzo, Ralph ;

Bannayan, George A. ;

Schenker, Steven ;

Cusi, Kenneth .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307

[9]

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach [J].

Bellentani, Stefano ;

Dalle Grave, Riccardo ;

Suppini, Alessandro ;

Marchesini, Giuho .

HEPATOLOGY, 2008, 47 (02) :746-754

[10]

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J].

Ben Sahra, I. ;

Laurent, K. ;

Loubat, A. ;

Giorgetti-Peraldi, S. ;

Colosetti, P. ;

Auberger, P. ;

Tanti, J. F. ;

Le Marchand-Brustel, Y. ;

Bost, F. .

ONCOGENE, 2008, 27 (25) :3576-3586

← 1 2 3 4 5 6 7 8 9 10 →